Rationalization and medical trials in oncology: Some remarks on the regulation of biomedical practices;Rationalisation et médecine des preuves en oncologie: Quelques remarques à propos de la régulation des pratiques biomédicales - Commentaire

Sciences Sociales et Sante

Volumn 23, Issue 4, 2005, Pages 41-48

  Cambrosio, Alberto ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29544434178     PISSN: 02940337     EISSN: None     Source Type: Journal    
DOI: 10.3406/sosan.2005.1664     Document Type: Note

References (26)

1. Barbot J., 2002, Les malades en mouvements, Paris, Balland.
2. Berg M., 1995, Turning a practice into a science. Reconceptualizing postwar medical practice, Social Studies of Science, 25, 437-476.
3. Berg M., 1996, Practices of reading and writing. The constitutive role of the patient record in medical work, Sociology of Health and Illness, 18, 499-524.
4. Berg M., 1997, Rationalizing medical work. Decision support techniques and medical practices, Cambridge (MA), MIT Press.
5. Bourret P., 2005, BRCA patients and clinical collectives: new configurations of action in cancer genetics practices, Social Studies of Science, 35, 41-68.
6. Bourret P., Mogoutov A., Julian-Reynier C., Cambrosio A., à paraître, A new clinical collective for French cancer genetics: a heterogeneous mapping analysis, Science, Technology, & Human Values.
7. Cambrosio A., Keating P., 2003, Qu'est-ce que la biomédecine ? Repères socio-historiques, Médecine/Sciences 19, 1280-1287.
8. Cambrosio A., Keating P., à paraître, Cancer clinical trials: new style of research, new forms of risks, In : Fantini B., Walter F., eds, Catastrophes and health. Risks perception between history and actuality, Genève, Presses de l'Université de Genève.
9. Cambrosio A., Keating P., Schlich T., Weisz G., à paraître, Regulatory objectivity and the generation and management of evidence in medicine, Social Science & Medicine.
10. Castel P., Merle I., 2002, Quand les normes de pratiques deviennent une ressource pour les médecins, Sociologie du Travail, 44, 337-355.
11. Daston L., 1992, Objectivity and the escape from perspective, Social Studies of Science, 22, 597-618.
12. Daston L., 1995, The moral economy of science, Osiris, 10, 2-24.
13. Dodier N., 1993, Les appuis conventionnels de l'action. Éléments de pragmatique sociologique, Réseaux, 65, 63-86.
14. Dodier N., 2003, Leçons politiques de l'épidémie du sida, Paris, Éditions de l'EHESS.
15. Epstein S., 1996, Impure science: AIDS, activism and the politics of knowledge, Berkeley, University of California Press.
16. Gaudillière J.P., 2002, Inventer la biomédecine : la France, l'Amérique et la production des savoirs du vivant (1945-1965), Paris, La Découverte.
17. Howell J.D., 1995, Technology in the hospital. Transforming patient care in the early twentieth century, Baltimore, The Johns Hopkins University Press.
18. Keating P., Cambrosio A., 2002, From screening to clinical research: the cure of leukemia and the early development of the cooperative oncology groups, 1955-1966, Bulletin of the History of Medicine, 76, 299-334.
19. Keating P., Cambrosio A., 2003a, Beyond «bad news»: the diagnosis, prognosis and classification of lymphomas and lymphoma patients in the era of biomedicine (1945-1995), Medical History, 47, 291-312.
20. Keating P., Cambrosio A., 2003b, Biomedical platforms. Realigning the normal and the pathological in late-twentieth-century medicine, Cambridge (MA), MIT Press.
21. Keating P., Cambrosio A., 2005, Risk on trial. The interaction of innovation and risk factors in clinical trials, In : Schlich T., Tröhler U., eds, The risks of medical innovation: risk perception and assessment in historical context, London, Routledge, 225-241.
22. Lynch M., 1982, Technical work and critical inquiry: investigations in a scientific laboratory, Social Studies of Science, 12, 499-533.
23. Marks H.M., 1997, The progress of experiments: science and therapeutic reform in the United States, 1900-1990, Cambridge (UK), Cambridge University Press.
24. Rabeharisoa V., 2003, The struggle against neuromuscular diseases in France and the emergence of the «partnership model»of patient organization, Social Science & Medicine, 57, 2127-2136.
25. Rabeharisoa V., Callon M., 2004, Patients and scientists in French muscular dystrophy research, In : Jasanoff S., ed., States of knowledge. The co-production of science and social order, London, Routledge.
26. Tournay V., à paraître, Collecter, centraliser, circuler, contraindre et répéter : cinq modalités pour standardiser les connaissances et les pratiques en matière d'innovation médicale, Quaderni, 58.